PharmaLogic announces opening of radiopharmaceutical production facility in New York City
PharmaLogic Holdings Corp., (“PharmaLogic” or “the company”), a world-class contract development and manufacturing organization (CDMO) and radiopharmacy solutions provider, celebrates the opening of its radiopharmaceutical production and research facility in the Bronx, New York. Acquired in 2022, the facility has undergone…
TekniPlex Healthcare Signs Definitive Purchase Agreement To Acquire Seisa Medical
TekniPlex Healthcare, which utilizes advanced materials science expertise to help deliver better patient outcomes, has signed a definitive agreement to acquire Seisa Medical in a deal that significantly extends TekniPlex Healthcare’s medical technology solutions platform. This acquisition specifically enhances the…
Piramal Pharma Solutions Launches In-Vitro Biology Capabilities at Ahmedabad Discovery Services Site
Piramal Pharma Limited’s Pharma Solutions (PPS) business, a leading Contract Development and Manufacturing Organization (CDMO), today formally announced the launch of a world-class high-throughput screening facility that augments the existing in-vitro biology capabilities at its drug discovery services site in…
WuXi Vaccines Launches Its First Vaccines CDMO Site in China
WuXi Vaccines, a leading contract development and manufacturing organization (CDMO) focused on vaccine discovery, development, and manufacturing, has launched its first standalone vaccines CDMO site in Suzhou, China. The opening will add drug substance and drug product capacity, with end-to-end…
LOTTE BIOLOGICS Holds ‘ESG Declaration Ceremony’
LOTTE BIOLOGICS is embarking on full-fledged ESG (Environmental, Social, and Governance) management. On August 30, LOTTE BIOLOGICS, under the leadership of CEO Richard Lee, held its ‘ESG Declaration Ceremony’ at the Executive Briefing Center (EBC) on the 113th floor of…
